Inflammatory Cardiomyopathy Bern Registry
Conditions: Myocarditis; Cardiac Sarcoidosis; Pericarditis Intervention: Sponsor: University Hospital Inselspital, Berne Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2021 Category: Research Source Type: clinical trials
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesAs of December, 1st, 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, resulted in more than 1 472 917 deaths worldwide and death toll is still increasing exponentially. Many COVID-19 infected people are asymptomatic or experience moderate symptoms and recover without medical intervention. However, older people and those with comorbid hypertension, diabetes, obesity, or heart disease are at higher risk of mortality. Because current therapeutic options for COVID-19 patients are limited specifically for this elderly population at risk, Biophytis is developing BIO101 (20-hydroxyecdysone, a Mas ...
Source: Trials - January 11, 2021 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
Condition: Pericarditis Interventions: Biological: RPH-104; Drug: Placebo Sponsors: R-Pharm International, LLC; Unimed Laboratories CJSC; Data Management 365 LLC; Covance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2021 Category: Research Source Type: clinical trials
